AzTrials
AzTrials

Premenstrual Dysphoric DisorderNCT05813366

Combined Effect of Tryptophan Rich Diet and Acupuncture on Depression Related to Premenstrual Dysphoric Disorder

A study testing Acupuncture, Tryptophan-Rich Diet and Vitamin B6 Supplementation in people with Premenstrual Dysphoric Disorder, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS) affecting up to 8% of reproductive age women. It is characterized by physical and psychological symptoms that occur in the luteal phase of the menstrual cycle, prior to the onset of menses, and leads to negative impact on the… Read more about this study

Who is it for?
Ages 20 to 30 years, women onlyHealthy volunteers can take part
Conditions the study is for
Premenstrual Dysphoric Disorder
What is being tested?
Acupuncture, Tryptophan-Rich Diet and Vitamin B6 Supplementation
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
No sites listed yet
Study dates
25 Apr 2023to 25 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 30 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All females will be clinically diagnosed with premenstrual dysphoric disorder (PMDD) as confirmed and referred from the gynaecologist.
  • All females will be firstly assessed by Hamilton Depression rating scale (HDRS) for two months to confirm depression related to PMDD before participating in the study.
  • Their ages will be ranged from 20 to 30 years.
  • Their BMI will be ranged from 20 to 25 kg/m.
  • Being virgin.
  • Having regular menstruation for the last 6 months (every 28- 35 days with no intermittent bleeding).
  • All females have a sedentary lifestyle.
  • Voluntary acceptance of participation in the study

Who cannot join

  • Using hormonal contraception (such as oral contraceptives and injections).
  • Menstrual irregularity.
  • Using diuretics or psychiatric medications.
  • Using chronic non-steroidal anti-inflammatory drugs.
  • Pre-diagnosed with any other psychological problems not related to PMDD.
  • Follow any exercise programs.

Trial locations and contacts

No sites are listed yet.

Nahla Mohamed Ashour contact

01050069089

nashour@horus.edu.eg

Manal Ahmed El-shafei contact

01220664518

manalpt1989@gmail.com

About this study

Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS) affecting up to 8% of reproductive age women. It is characterized by physical and psychological symptoms that occur in the luteal phase of the menstrual cycle, prior to the onset of menses, and leads to negative impact on the psychosocial functioning of affected individuals.

Selective serotonin reuptake inhibitors are usually used to treat PMDD but they have several side effects so it is important to use complementary treatment such as tryptophan-rich diet and acupuncture for women with PMDD . The purpose of the current study is to determine the combined effect of tryptophan-rich diet and acupuncture on depression related to premenstrual dysphoric disorder

Read the detailed description

This study will be conducted on 39 participants suffering from premenstrual dysphoric disorder (PMDD). They will be recruited from Horus University, New Damietta, Egypt.

Being tested
Acupuncture, Tryptophan-Rich Diet, Vitamin B6 Supplementation
Medical subject headings
Premenstrual Dysphoric Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AcupunctureOther

    Tony disposable, single-use 0.20×40 mm Chinese needles will be used. The needle penetrates the skin sufficiently to reach the required depth and elicit de qi. The needles remains for 30 min, with gentle rotational movements applied three times during the session.

  • Tryptophan-Rich DietOther

    All participants in both groups (A and C) will be treated by high protein foods rich with tryptophan including: chicken , turkey, red meat, salmon, fish, tuna, beans, milk, cheese, seeds, nuts, egg, banana, kiwi, leafy greens, mushroom, broccoli and peas, etc.

    Total daily calorie intake will be calculated for each participant in both groups (A and C) before diet description. All females will serve the meals that met their required kilocalorie levels and physical activity levels so that the participants will not lose weight, feel hungry or be over-fed.

  • Vitamin B6 SupplementationOther

    All participants in all groups (A, B and C) will receive a tablet of vitamin B6 60mg once/day for 8 weeks, starting from the first day of their menstrual cycle, throughout two menstrual cycles.

Study groups in NCT05813366
Study groupRoleWhat they receive
Tryptophan rich diet + vitamin B6 supplementationExperimentalIt will include 13 participants suffering from premenstrual dysphoric disorder (PMDD) who will be treated by diet rich wit tryptophan (high protein diet) for 8 weeks in addition to vitamin B6 tablets 60 mg once/day, throughout two menstrual cycles, starting from the first day of their menstrual cycle
Receives: Other: Tryptophan-Rich Diet; Other: Vitamin B6 Supplementation
Acupuncture + Vitamin B6 supplementationExperimentalIt will include 13 participants suffering from premenstrual dysphoric disorder (PMDD) who will be treated by acupuncture twice a week for 8 weeks, resulting in a total of 16 visits. Each visit, including initial care, needle application and needle retention, will last about 45 min. In addition to vitamin B6 tablet 60mg once/day, throughout two menstrual cycles, starts from the first day of their menstrual cycle
Receives: Other: Acupuncture; Other: Vitamin B6 Supplementation
Acupuncture + Tryptophan rich diet + vitamin B6 supplementationExperimentalIt will include 13 participants suffering from premenstrual dysphoric disorder (PMDD) who will be treated by diet rich with tryptophan (high protein diet) for 8 weeks and acupuncture twice a week for 8 weeks, resulting in a total of 16 visits. Each visit, including initial care, needle application and needle retention, will last about 45 min. In addition to vitamin B6 tablet 60mg once/day, throughout two menstrual cycles, starts from the first day of their menstrual cycle
Receives: Other: Acupuncture; Other: Tryptophan-Rich Diet; Other: Vitamin B6 Supplementation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Premenstrual Symptoms Screening Tool (PSST)

    It is a validated, simple, user-friendly screening tool to identify women who suffer from severe Premenstrual Syndrome (PMS) or Premenstrual Dysphoric Disorder (PMDD). It reflects and 'translates' categorical Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria into a rating scale with degrees of severity (Not at all, mild, moderate, severe). The scoring will be as follows:

    the following criteria must be present for a diagnosis of PMDD:

    • At least one of #1, #2, #3, and #4 is severe.
    • In addition at least four of #1 - #14 are moderate to severe.
    • At least one of A, B, C, D and E is severe.

    Measured: Up to 2 months

  2. Hamilton Depression Rating Scale (HDRS)

    The HDRS (also known as the Ham-D) is the most widely used clinician-administered depression assessment scale. HRSD provides a reliable and valid assessment of depression.

    Method for scoring varies by version. For the HDRS17, a score of 0 - 9 is generally accepted to be within the normal range, 10 - 13 mild, 14-17 mild to moderate and >17 moderate to severe

    Measured: Up to 2 months

Secondary outcomes (1)
  1. Quality of Life Enjoyment and Satisfaction Questionnaire - short form

    It evaluates overall enjoyment and satisfaction with physical health, mood, work, household and leisure activities, social and family relationships, daily functioning, sexual life, economic status, overall well-being and medications.

    Responses are scored on a 5-point scale ("very poor" to "very good"), where higher scores indicate better enjoyment and satisfaction with life (possible range 14-70). Previous study had shown that it is reliable, valid and sensitive assessments of the individuals' quality of life (QOL)

    Measured: Up to months 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2023
  2. Study start25 Apr 2023 (estimated)
  3. Primary completion25 Jun 2023 (estimated)
  4. Study completion25 Jul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
39 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05813366
Sponsor's protocol ID
P.T.REC/012/003877
Status last verified
Apr 2023
First submitted
30 Mar 2023
Last updated
14 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Acupuncture, Tryptophan-Rich Diet and Vitamin B6 Supplementation in people with Premenstrual Dysphoric Disorder, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nahla Mohamed Ashour (01050069089, nashour@horus.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Premenstrual Symptoms Screening Tool (PSST) (time frame: Up to 2 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in